Literature DB >> 34179859

Mucormycosis or black fungus is a new fright in India during covid-19 pandemic: Associated risk factors and actionable items.

Amena Ahmed Moona1, Md Rabiul Islam1.   

Abstract

Entities:  

Keywords:  Antibiotics; Black fungus; Covid-19 pandemic; Mucormycosis; Steroids

Year:  2021        PMID: 34179859      PMCID: PMC8215889          DOI: 10.1016/j.puhip.2021.100153

Source DB:  PubMed          Journal:  Public Health Pract (Oxf)        ISSN: 2666-5352


× No keyword cloud information.
Dear Editor, Mucormycosis or black fungus infection is a rare but deadly disease with a 46–96% mortality rate depending on the underlying health condition of patients [1]. This life-threatening new enemy has challenged the Indian healthcare system during the massive second wave of covid-19 pandemic [2]. Mucormycosis caused by the mucorales group of fungi affecting various parts of the body. This opportunistic fungal infection progress rapidly. Recently, the covid patients in India are getting infected by this uncommon fungus at higher rates than ever. At present, the prevalence of this black fungus infection is skyrocketing among covid-19 and post-covid-19 patients in India. As of June 8, 2021, India recorded 28,252 mucormycosis cases. Among them, 86.0% had a history of covid-19 and 62.3% had a history of diabetes [3]. Therefore, the health experts are projecting the actual prevalence is much higher than the reported cases. The reported prevalence of black fungus infection in India is nearly 70 times higher than the global data [4]. Generally, black fungus affects the body surface and internal organs such as the sinus, brain, lungs, eyes, bones, nerves, body tissues and becomes fatal if left untreated [5]. Usual signs of this disease are sinus pain, nasal blockage on one side of the face, swelling or numbness, one-sided headache, loosening of tooth and toothache, pain in the eyes, and more. The infected patients primarily suffer from eyelid loss, blindness, and blurred vision [6]. Therefore, the early detection of this fungal infection is a big challenge for the physicians because the patients do not go to physicians, or doctors often fail to recognize this disease in the early stage. As a result, it frequently requires the removal of an eye or both to stop the spread of infection. India has never faced such a high prevalence of black fungus infection. So, the recent spike of this fungal infection in India was unanticipated. Black fungus is an opportunistic pathogen that affects immune-compromised patients due to comorbidities, excessive administration of steroids, organ transplantation, exposure to ventilation, oxygen therapy, poor hospital hygiene, etc. [7] A recent summary of the Indian black fungus infection upsurge indicates that 94% of patients had diabetes. In India, the black fungus victims are mainly covid-19 and post-covid-19 patients. The airways of covid patients are favorable for black fungus due to the exposure to humidity and moisture during ventilation in ICU. Besides, the indiscriminate use of steroids and antibiotics for treating covid-19 patients might create chance for this opportunistic fungus. Therefore, health experts primarily suspected overmedication, hospital hygiene, and comorbid diseases as possible contributing factors for this sharp spike of black fungus infection during the catastrophic second wave of the covid-19 pandemic in India [8]. Besides, people in India have a tendency to alternative therapy for covid-19 like cow dung and urine to cure covid. Many people in India consume cow dung and urine under branded “cow dung therapy” for covid cure [9]. There is no scientific evidence supporting this behavior of using byproducts of cows to boost immunity against diseases. Moreover, the behavior can spread other diseases from animals to the human body, for example, mucormycosis, because animal dung is a potential host for black fungus. Therefore, we assume the wide use of cow dung and urine might contribute to this epidemic[10]. The health experts suspect the overuse of medication is a potential contributing factor for black fungus infection. So, the public healthcare authority should ensure the rational use of steroids and antibiotics to manage the ongoing pandemic. Also, the government should immediately stop the over-the-counter use of antibiotics and steroids. Awareness and early diagnosis are the keys to halting the spread of the infection. Diabetic patients should be advised and encouraged to control their glucose levels. There should be enough testing facilities for black fungus. The healthcare authorities should maintain regular communication with all covid and post-covid patients for early assessment and detection of this deadly black fungus infection. The government authority must ban any gathering for smearing cow dung and urine and encourage them to follow health safety rules. Treatment of black fungus infection and antifungal medications should be made affordable and available for general population. Therefore, the authorities can immediately set up ad hoc units in hospitals and encourage the companies to produce adequate antifungal drugs. Also, the authorities should enforce quality control and compliance in the way of delivering oxygen to covid-19 patients.

Funding

The author(s) didn't receive any financial support for this work.

Ethics statement

Not applicable for this study.

Declaration of competing interest

The author(s) don't have any conflict of interest to declare.
  6 in total

Review 1.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

2.  The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports.

Authors:  W Jeong; C Keighley; R Wolfe; W L Lee; M A Slavin; D C M Kong; S C-A Chen
Journal:  Clin Microbiol Infect       Date:  2018-07-21       Impact factor: 8.067

3.  A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment.

Authors:  Hariprasath Prakash; Anup Kumar Ghosh; Shivaprakash Mandya Rudramurthy; Pankaj Singh; Immaculata Xess; Jayanthi Savio; Umabala Pamidimukkala; Joseph Jillwin; Subhash Varma; Ashim Das; Naresh K Panda; Surjit Singh; Amanjit Bal; Arunaloke Chakrabarti
Journal:  Med Mycol       Date:  2019-06-01       Impact factor: 4.076

4.  The massive attack of COVID-19 in India is a big concern for Bangladesh: The key focus should be given on the interconnection between the countries.

Authors:  Sohel Daria; Md Asaduzzaman; Mohammad Shahriar; Md Rabiul Islam
Journal:  Int J Health Plann Manage       Date:  2021-05-19

5.  The use of cow dung and urine to cure COVID-19 in India: A public health concern.

Authors:  Sohel Daria; Md Rabiul Islam
Journal:  Int J Health Plann Manage       Date:  2021-05-26
  6 in total
  15 in total

1.  Indiscriminate Use of Antibiotics for COVID-19 Treatment in South Asian Countries is a Threat for Future Pandemics Due to Antibiotic Resistance.

Authors:  Sohel Daria; Md Rabiul Islam
Journal:  Clin Pathol       Date:  2022-05-18

2.  A cross-sectional study of COVID-19-related knowledge, risk perceptions, and preventive practices among pharmacy students in Bangladesh.

Authors:  Sadia Afruz Ether; Faisal Abdullah Emon; Asm Roknuzzaman; Md Rakibuzzaman; Fahad Imtiaz Rahman; Md Rabiul Islam
Journal:  SAGE Open Med       Date:  2022-01-18

3.  The COVID-19 vaccination experience in Bangladesh: Findings from a cross-sectional study.

Authors:  Md Rabiul Islam; Moynul Hasan; Waheeda Nasreen; Md Ismail Tushar; Mohiuddin Ahmed Bhuiyan
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

4.  Delta variant and black fungal invasion: A bidirectional assault might worsen the massive second/third stream of COVID-19 outbreak in South-Asia.

Authors:  M S Bari; M J Hossain; S Akhter; T B Emran
Journal:  Ethics Med Public Health       Date:  2021-09-04

5.  Upsurge of Dengue Prevalence During the Third Wave of COVID-19 Pandemic in Bangladesh: Pouring Gasoline to Fire.

Authors:  Fahad Imtiaz Rahman; Sadia Afruz Ether; Md Rabiul Islam
Journal:  Clin Pathol       Date:  2022-02-03

6.  The SARS-CoV-2 Omicron (B.1.1.529) variant and the re-emergence of COVID-19 in Europe: An alarm for Bangladesh.

Authors:  Md Rabiul Islam
Journal:  Health Sci Rep       Date:  2022-03-13

7.  New Coronavirus Variants are Creating More Challenges to Global Healthcare System: A Brief Report on the Current Knowledge.

Authors:  Salsabil Islam; Towhidul Islam; Md Rabiul Islam
Journal:  Clin Pathol       Date:  2022-02-03

8.  Molecular signature of postmortem lung tissue from COVID-19 patients suggests distinct trajectories driving mortality.

Authors:  Anshul Budhraja; Anubhav Basu; Atish Gheware; Dasari Abhilash; Seesandra Rajagopala; Suman Pakala; Madhuresh Sumit; Animesh Ray; Arulselvi Subramaniam; Purva Mathur; Aruna Nambirajan; Sachin Kumar; Ritu Gupta; Naveet Wig; Anjan Trikha; Randeep Guleria; Chitra Sarkar; Ishaan Gupta; Deepali Jain
Journal:  Dis Model Mech       Date:  2022-06-06       Impact factor: 5.732

9.  The Upsurge of Diarrhea Amid COVID-19 Pandemic Makes Matter Worse in Bangladesh: A Call to Action.

Authors:  Smaranika Rahman; Md Jamal Hossain; Md Rabiul Islam
Journal:  Gerontol Geriatr Med       Date:  2022-08-08

10.  Mucormycosis or black fungus infection is a new scare in South Asian countries during the COVID-19 pandemic: Associated risk factors and preventive measures.

Authors:  Fahad I Rahman; Md Rabiul Islam; Mohiuddin A Bhuiyan
Journal:  J Med Virol       Date:  2021-07-22       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.